Clinical and Economic Outcomes of Nonadherence to Highly Active Antiretroviral Therapy in Patients With Human Immunodeficiency Virus - Concepedia

Concepedia

Publication | Closed Access

Clinical and Economic Outcomes of Nonadherence to Highly Active Antiretroviral Therapy in Patients With Human Immunodeficiency Virus

47

Citations

37

References

2006

Year

Julie Munakata, Joshua S. Benner, Stephen Becker, Christopher M. Dezii, Elisabeth Hazard, Jonothan C. Tierce

Abstract

Typical adherence with HAART reduces quality-adjusted life expectancy by 12% compared with ideal adherence. Interventions to improve adherence appear to be a highly cost-effective use of resources.

References

	Year	Citations

Page 1